Stanley T. Crooke
2017
In 2017, Stanley T. Crooke earned a total compensation of $7.3M as Chairman, President, Chief Executive Officer at Ionis Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
| Bonus | $1,006,068 |
|---|---|
| Option Awards | $4,113,250 |
| Salary | $849,271 |
| Stock Awards | $1,306,509 |
| Other | $39,554 |
| Total | $7,314,652 |
Crooke received $4.1M in option awards, accounting for 56% of the total pay in 2017.
Crooke also received $1M in bonus, $849.3K in salary, $1.3M in stock awards and $39.6K in other compensation.
Rankings
In 2017, Stanley T. Crooke's compensation ranked 1,094th out of 14,666 executives tracked by ExecPay. In other words, Crooke earned more than 92.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,094 out of 14,666 | 93rd |
Division Manufacturing | 366 out of 5,772 | 94th |
Major group Chemicals And Allied Products | 97 out of 2,075 | 95th |
Industry group Drugs | 65 out of 1,731 | 96th |
Industry Pharmaceutical Preparations | 53 out of 1,333 | 96th |
Source: SEC filing on April 26, 2019.
Crooke's colleagues
We found five more compensation records of executives who worked with Stanley T. Crooke at Ionis Pharmaceuticals in 2017.
2017
B Parshall
Ionis Pharmaceuticals
Chief Operating Officer
2017
Brett Monia
Ionis Pharmaceuticals
Chief Operating Officer
2017
Richard Geary
Ionis Pharmaceuticals
Senior Vice President, Development
2017
Patrick O'Neil
Ionis Pharmaceuticals
General Counsel
2017
Elizabeth Hougen
Ionis Pharmaceuticals